Telomere length and telomerase reverse transcriptase gene copy number in patients with papillary thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 11, 2011, Pages

  Jendrzejewski, Jaroslaw ^a   Tomsic, Jerneja ^a   Lozanski, Gerard ^b   Labanowska, Jadwiga ^b   He, Huiling ^a   Liyanarachchi, Sandya ^a   Nagy, Rebecca ^a   Ringel, Matthew D ^b   Kloos, Richard T ^b   Heerema, Nyla A ^b   De La Chapelle, Albert ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TELOMERE; THYROID PAPILLARY CARCINOMA; VALIDATION STUDY;

ADULT; CARCINOMA, PAPILLARY; FEMALE; GENE DOSAGE; HUMANS; MALE; MIDDLE AGED; RNA, MESSENGER; TELOMERASE; TELOMERE; THYROID NEOPLASMS;

EID: 80655147225     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1643     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ 2007 Cancer statistics, 2007. CA Cancer J Clin 57:43-66 (Pubitemid 46148091)
2. Dong C, Hemminki K 2001 Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 92:144-150 (Pubitemid 32187044)
3. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH 1994 Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600-1608 (Pubitemid 24336346)
4. Jazdzewski K, Liyanarachchi S, Swierniak M, Pachucki J, Ringel MD, Jarzab B, de la Chapelle A 2009 Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci USA 106:1502-1505
5. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A 2008 Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 105:7269-7274 (Pubitemid 351754467)
6. He H, Nagy R, Liyanarachchi S, Jiao H, Li W, Suster S, Kere J, de la Chapelle A 2009 A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res 69:625-631
7. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K 2009 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41:460-464
8. Fagin JA 1997 Familial nonmedullary thyroid carcinoma: the case for genetic susceptibility. J Clin Endocrinol Metab 82:342-344 (Pubitemid 27068588)
9. Ito Y, Kakudo K, Hirokawa M, Fukushima M, Yabuta T, Tomoda C, Inoue H, Kihara M, Higashiyama T, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A 2009 Biological behavior and prognosis of familial papillary thyroid carcinoma. Surgery 145:100-105
10. Uchino J, Takayama K, Harada A, Kawakami Y, Inoue H, Curiel DT, Nakanishi Y 2005 Infectivity enhanced, hTERT promoterbased conditionally replicative adenoviruses are useful for SCLC treatment. Cancer Gene Ther 12:737-748 (Pubitemid 41208613)
11. Capezzone M, Cantara S, Marchisotta S, Filetti S, De Santi MM, Rossi B, Ronga G, Durante C, Pacini F 2008 Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients. J Clin Endocrinol Metab 93:3950-3957
12. Cantara S, Capuano S, Formichi C, Pisu M, Capezzone M, Pacini F 2010 Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer. Thyroid Res 3:4
13. Cawthon RM 2002 Telomere measurement by quantitative PCR. Nucleic Acids Res 30:e47
14. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25:402-408 (Pubitemid 34164012)
15. Baerlocher GM, Vulto I, de Jong G, Lansdorp PM 2006 Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc 1:2365-2376
16. Nawrot TS, Staessen JA, Gardner JP, Aviv A 2004 Telomere length and possible link to X chromosome. Lancet 363:507-510 (Pubitemid 38229449)
17. Nordfjäll K, Larefalk A, Lindgren P, Holmberg D, Roos G 2005 Telomere length and heredity: Indications of paternal inheritance. Proc Natl Acad Sci USA 102:16374-16378 (Pubitemid 41688921)
18. Okuda K, Bardeguez A, Gardner JP, Rodriguez P, Ganesh V, Kimura M, Skurnick J, Awad G, Aviv A 2002 Telomere length in the newborn. Pediatr Res 52:377-381 (Pubitemid 34920268)
19. Hewakapuge S, van Oorschot RA, Lewandowski P, Baindur-Hudson S 2008 Investigation of telomere lengths measurement by quantitative real-time PCR to predict age. Leg Med (Tokyo) 10:236-242
20. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA 2003 Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361:393-395 (Pubitemid 36164975)